MIF and asthma: The first small molecule MIF inhibitor to be described is ISO-1, which binds to the MIF tautomerase active site and inhibits downstream signaling [47] and has been shown to inhibit OVA and HDM-induced airway remodeling in a mouse model of asthma [48, 49].